Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney Injury

Sandeep Brar¹,
Kathleen D. Liu²,
Alan S. Go³,⁴,
Raymond K. Hsu³,
Vernon M. Chinchilli⁵,
Steven G. Coca⁶,
Amit X. Garg⁷,
Jonathan Himmelfarb⁸,
T. Alp Ikizler⁹,
James Kaufman¹⁰,
Paul L. Kimmel¹¹,
Chirag R. Parikh¹²,
Edward D. Siew⁹,¹³,
Lorraine B. Ware¹⁴,
Hui Zeng⁵,
Chi-yuan Hsu³,⁴,
for the ASsessment, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) study investigators*

¹Department of Epidemiology and Biostatistics, University of California, San Francisco, California
²Departments of Medicine and Anesthesia, University of California, San Francisco, California
³Division of Nephrology, University of California, San Francisco School of Medicine, San Francisco, California
⁴Division of Research, Kaiser Permanente Northern California, Oakland, California
⁵Department of Public Health Sciences, Pennsylvania State University College of Medicine, Hershey, Pennsylvania
⁶Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York
⁷Department of Medicine, Epidemiology and Biostatistics, Western University, London, Ontario, Canada
⁸Division of Nephrology, University of Washington, Seattle, Washington
⁹Division of Nephrology and Hypertension and Vanderbilt Center for Kidney Disease, Vanderbilt University Medical Center, Nashville, Tennessee
¹⁰Renal Section, Veterans Affairs New York Harbor Healthcare System and New York University School of Medicine, New York, New York
¹¹Division of Kidney, Urologic and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
¹²Division of Nephrology, Johns Hopkins School of Medicine, Baltimore, Maryland
¹³Tennessee Valley Health Services Nashville Veterans Affairs Hospital, Nashville, Tennessee
¹⁴Departments of Medicine and Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee

Correspondence:
Dr. Chi-yuan Hsu, Division of Nephrology, University of California, San Francisco School of Medicine, 533 Parnassus Avenue, U-400, Box 0532 San Francisco, CA 94143-0532. Email: chi-yuan.hsu{at}ucsf.edu

↵* The ASSESS-AKI Investigators are James Kaufman (Chair, Steering Committee; New York University School of Medicine); Vernon M. Chinchilli, Nasrollah Ghahramani, W. Brian Reeves, Lan Kong, Ming Wang, and Elana Farace (Data Coordinating Center; Pennsylvania State University); Alan Go, Chi-yuan Hsu, Kathleen Liu, Raymond Hsu, Thida Tan, Juan D. Ordonez, and Sijie Zheng (Kaiser Permanente Northern California/University of California, San Francisco); T. Alp Ikizler, Edward D. Siew, Julia B. Lewis, and Lorraine Ware (Vanderbilt University); Chirag Parikh, Steven Coca, and Dennis G. Moledina (Yale University); Amit X. Garg (Western University); Prasad Devarajan (Cincinnati Children's Hospital); Michael Zappitelli (McGill University); Jonathan Himmelfarb and Mark Wurfel (University of Washington); Paul L. Kimmel, Paul W. Eggers, and Marva M. Moxey-Mims (National Institute of Diabetes and Digestive and Kidney Diseases).